Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s):  CLAZF

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID... see more

TSXV:CLAS.H - Post Discussion

Claritas Pharmaceuticals Inc > Letter from Robert Farrell. Summary:
View:
Post by deanthebean on May 25, 2020 7:32am

Letter from Robert Farrell. Summary:

- they are going in heavy with the covid-19 treatment
- actively pursuing a sale of the GVHD
- kal-1816 pain relief; they are advancing the program through phase 1 and 2
- announced private placement expected closing date

so in summary we are currently a covid play it seems. Let's hope there is real substance to it and it's not just being pushed to the forefront in order to give excitement to the private placement!
Comment by Theknocker91 on May 25, 2020 7:40am
The only thing about this news release which will apply downward pressure to the stock is the private placement at 0.015
Comment by TheKneeH on May 25, 2020 8:11am
The NR also reminds us that Kly is in default towards Talent. They're essentially telling us to vote 'yes' for the deal or they lose the GvHD program.
Comment by MiSdyngNASTY on May 25, 2020 8:13am
This 5 million private placement that they aren't going to get is an attempt to pay the debt owing to Talent. What a scam.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities